Key result
An intraluminally placed obturator reduced aortic regurgitation by 15% to 38% compared with control values, with only small increases in transvalvular gradients.
Why the study?
Does an intraluminal obturator reduce aortic regurgitation in an in vitro model using explanted human aortic valves?
Does an intraluminal obturator reduce aortic regurgitation in an in vitro model using explanted human aortic valves?
An intraluminal obturator prototype significantly reduces aortic regurgitation in an in vitro model with minimal impact on transvalvular gradients, demonstrating feasibility for future device development.
Answers are grounded in this paper and cite their sources.
Should not yet change practice; hypothesis-generating for intraluminal obturators as bridge therapy in aortic regurgitation.
OBJECTIVES: Development of an intraluminal device to reduce aortic regurgitation could provide a strategy intermediate between medical treatment and aortic valve replacement. An initial prototype and a testing system have been designed. METHODS: Aortic valves obtained from heart transplant recipients were explanted and assessed in a mock circulatory loop with resistive and capacitive elements, including pressure-flow characteristics, similar to those of a normal arterial system. Normal heart function was simulated by a pulsatile ventricular-assist device. Pressure on each side of the valve and flow through the valve were recorded, allowing the calculation of regurgitant fractions and transvalvular gradients. Six solid geometrically differing obturators were tested. RESULTS: All six designs resulted in significant reduction in aortic regurgitation (p < 0.0001), ranging from 15% to 38% improvement compared with control values. Small increases in transvalvular gradients (from 0 to 7 mm Hg) were also noted. DISCUSSION: Initial results suggest that an intraluminally placed obturator can reduce aortic regurgitation without creating clinically significant transvalvular gradients. These initial in vitro experiments demonstrate the feasibility of an intraluminal device for the treatment of aortic valve disease, and further investigation is warranted.
No takes yet. Share an insight, caveat, or question.
Ashton et al. (1996) studied Aortic regurgitation. Intraluminal device (obturator) vs. Control values (without obturator) was evaluated on Reduction in aortic regurgitation (15% to 38% improvement, p=< 0.0001). An intraluminally placed obturator reduced aortic regurgitation by 15% to 38% compared with control values, with only small increases in transvalvular gradients.
Synapse has enriched 10 related papers. Consider them for comparative context: